Physician profile
Michael Hiroshi Johnson
NPI 1770710469
$160,163.85
in general payments reported to CMS, 2019-2025
29 companies · $8,768 in 2025
The $8,768 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.00 · 2021: $8,857 · 2022: $58K · 2023: $61K · 2024: $24K · 2025: $8,768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $56K · Travel and Lodging: $12K · Education: $12K · Consulting Fee: $6,694 · Food and Beverage: $6,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $56,145.00 |
| Travel and Lodging | $12,116.29 |
| Education | $12,019.81 |
| Consulting Fee | $6,693.50 |
| Food and Beverage | $6,293.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $90,300.80 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $31,027.49 | 2022-2025 | Erleada, Akeega, Balversa |
| Intuitive Surgical, INC. | $13,535.41 | 2023-2025 | Da Vinci Surgical System |
| Dendreon Pharmaceuticals LLC | $6,579.58 | 2022 | |
| Siemens Medical Solutions USA, INC. | $6,525.00 | 2021 | |
| Teleflex LLC | $2,718.60 | 2021-2025 | Urolift, Barrigel |
| Pfizer INC. | $2,418.00 | 2023-2025 | |
| Edap Technomed INC | $2,027.61 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,691.29 | 2024-2025 | Imfinzi |
| Urogen Pharma, INC. | $640.58 | 2021-2025 | |
| Procept Biorobotics Corporation | $492.25 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $348.00 | 2021-2025 | Lumenis Pulse 120h, Lithovue, General - Kidney Stone Disease |
| Bayer Healthcare Pharmaceuticals INC. | $331.52 | 2022-2023 | |
| Coloplast Corp | $310.39 | 2021 | |
| Janssen Scientific Affairs, LLC | $263.29 | 2024-2025 | Erleada |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $194.14 | 2024 | |
| Sumitomo Pharma America, INC. | $191.52 | 2023-2024 | Orgovyx, Gemtesa |
| Calyxo, INC. | $161.05 | 2025 | Cvac Aspiration System |
| Tempus Ai, INC | $100.00 | 2024 | |
| Abbvie INC. | $59.74 | 2022-2025 | |
| Profound Medical Corp. | $59.59 | 2022 | |
| Myovant Sciences INC. | $56.46 | 2022 | |
| Abc Home Medical Supply, INC. | $41.92 | 2025 | |
| Neotract INC. | $29.00 | 2020 | |
| Axonics, INC. | $22.71 | 2024 | Axonics |
| Astellas Pharma US INC | $20.49 | 2023 | Xtandi |
| Acera Surgical, INC. | $13.60 | 2024 | Restrata Wound Matrix |
| Travere Therapeutics, INC. | $3.82 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.